Showing results (1251-1260 of 1,395) with videos related to
Sort By:
Pageof 140
JCI Insight|July 13, 2018
Spatial and temporal variations in hemodynamic forces initiate cardiac trabeculationJuhyun Lee, Vijay Vedula, Kyung In Baek, et al.Nature Cardiovascular Research|May 20, 2024
Histone H1.0 couples cellular mechanical behaviors to chromatin structureShuaishuai Hu, Douglas J Chapski, Natalie D Gehred, et al.Atherosclerosis|February 28, 2012
Apolipoprotein E genotype and the cardiovascular disease risk phenotype: impact of sex and adiposity (the FINGEN study)Bettina M Kofler, Elizabeth A Miles, Peter Curtis, et al.Atherosclerosis|February 12, 2008
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPEREliana Polisecki, Hind Muallem, Nobuyo Maeda, et al.Cancer Research|April 25, 2019
Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic OsteosarcomaElizabeth R Butch, Paul E Mead, Victor Amador Diaz, et al.Circulation. Genomic and Precision Medicine|April 2, 2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular MedicineDavid Rhainds, Chris J Packard, Mathieu R Brodeur, et al.JCI Insight|August 30, 2022
Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutationsMarja-Riitta Taskinen, Elias Björnson, Niina Matikainen, et al.Endocrinology|October 28, 2017
Dietary Manipulations That Induce Ketosis Activate the HPA Axis in Male Rats and Mice: A Potential Role for Fibroblast Growth Factor-21Karen K Ryan, Amy E B Packard, Karlton R Larson, et al.Journal of Virology|May 31, 2013
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virusRajini Mudhasani, Julie P Tran, Cary Retterer, et al.Plos One|September 12, 2013
Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Suzanne M Lloyd, David J Stott, Anton J M de Craen, et al.Pageof 140